Black Patients Still Underrepresented in Clinical Trials
Black patients remain underrepresented in US clinical trials despite the Food and Drug Administration's 2015 launch of a 5-year plan to improve the situation, a new study finds.
Reuters Health Information
source https://www.medscape.com/viewarticle/970050?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/970050?src=rss
Comments
Post a Comment